AI Verdict
MRK has stronger fundamentals based on our AI analysis.
MRK vs ZTS Fundamental Comparison
| Metric | MRK | ZTS |
|---|---|---|
| Revenue | $65.0B | $9.5B |
| Net Income | $18.3B | $2.7B |
| Net Margin | 28.1% | 28.2% |
| ROE | 34.7% | 80.2% |
| ROA | 13.3% | 17.3% |
| Current Ratio | 1.54x | 3.03x |
| Debt/Equity | 0.89x | 2.71x |
| EPS | $7.28 | $6.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MRK vs ZTS: Frequently Asked Questions
Is MRK or ZTS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MRK has stronger fundamentals. MRK is rated BUY (80% confidence) while ZTS is rated BUY (78% confidence). This is not investment advice.
How does MRK compare to ZTS fundamentally?
Merck & Co., Inc. has ROE of 34.7% vs Zoetis Inc.'s 80.2%. Net margins are 28.1% vs 28.2% respectively.
Which stock pays higher dividends, MRK or ZTS?
MRK has a dividend yield of N/A or no dividend while ZTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MRK or ZTS for long term?
For long-term investing, consider that MRK has BUY rating with 80% confidence, while ZTS has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MRK vs ZTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MRK vs ZTS, the AI consensus favors MRK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.